ACCESS Newswire
24 May 2023, 21:58 GMT+10
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape.
This recent growth is an extension of the successful launch of Northway Biotech's process and analytical development laboratories in Waltham (Greater Boston area) in 2020. The expanded facility now includes state-of-the-art cGMP suites, marking a significant milestone in the company's journey. The newly established cutting-edge biomanufacturing suites host a microbial fermentation train with up to 450 liters of volume capacity, and a mammalian production train with the ability to handle volumes of up to 2,000 liters. Northway Biotech has further established a specialized, fully automated fill and finish line to accommodate its clients' varied needs, supporting high-throughput filling into vials, syringes, and cartridges.
Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech, shared his insights regarding this accomplishment, stating, 'The addition of GMP suites in our US site represents a transformative step for our organization, enabling us to provide comprehensive end-to-end solutions from our second site now. We are poised to transition current process development projects into the cGMP manufacturing phase in a timely manner, in line with our clients' committed schedules. Additionally, our longstanding US partners who have engaged with our Lithuanian site can now also take advantage of the geographical convenience of our modern facilities located in the Greater Boston Area. With our fully functional and technologically advanced manufacturing site at our disposal, Northway Biotech is perfectly positioned to take on manufacturing projects aimed at both clinical and commercial supply.'
To commemorate this significant expansion and express gratitude to its valued partners and industry leaders, Northway Biotech will be hosting a grand opening event for its cGMP suites on June 8. This event promises to be an occasion of celebration and networking, providing an opportunity for attendees to witness firsthand the state-of-the-art facilities and engage in meaningful discussions within the biotech community.
About Northway Biotech - https://www.northwaybiotech.com
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced, professional team executes projects at any stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately-owned company founded in 2004 and located in Vilnius, Lithuania; London, United Kingdom; and Waltham, Massachusetts, United States.
For Further Information, Contact:
Prof. Vladas Algirdas Bumelis
CEO and Chairman of the Board
Northway Biotech
[email protected]
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
[email protected]
SOURCE: Northway Biotech
Get a daily dose of Dallas Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Dallas Sun.
More InformationATLANTA, Georgia: A judge in Georgia has ruled that Delta Air Lines can continue most of its lawsuit against the cybersecurity company...
WASHINGTON, D.C.: U.S. senators from both parties introduced a bill this week aimed at countering China and Russia's growing influence...
NEW YORK CITY, New York: Officials are investigating why a Mexican Navy training ship hit the Brooklyn Bridge on May 17, breaking the...
WASHINGTON, D.C.: The U.S. Department of Justice wants to merge two of its agencies — the Drug Enforcement Administration and the Bureau...
MADRID, Spain: Spain has ordered Airbnb to remove more than 65,000 holiday rental listings from its platform, accusing the company...
WASHINGTON, D.C.: Families of some of the 346 people who died in two deadly Boeing 737 MAX crashes plan to oppose a proposed deal between...
SAN FRANCISCO, California: Levi Strauss is parting ways with Dockers. The denim giant announced this week that it will sell the Dockers...
OTTAWA, Canada: Canada's inflation picture became more complicated in April, with headline inflation easing but core measures ticking...
NEW YORK, New York - U.S. stocks had a volatile day on Thursday after the House of Representatives narrowly passed President Donald...
ATLANTA, Georgia: Home Depot plans to hold prices steady despite the added strain of tariffs, the company said, but warned that some...
WASHINGTON, D.C.: The U.S. Department of Justice dropped a lawsuit last week against Southwest Airlines. The lawsuit, filed near the...
KUALA LUMPUR, Malaysia: Airbus is in discussions with Malaysian airlines to introduce its A220 aircraft, the company's Asia-Pacific...